Recently, NEJM published the 1-year results of the FAME-3 study, where fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) with current-generation drug-eluting stents (DES) was not found non-inferior to coronary artery by-pass grafting (CABG) in patients with three-vessel coronary artery disease .